Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-19-029668

Chief Scientific Officer acquired 4,124 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Douville Philippe · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-13 Conversion : show line 1 in the form +4,124 43,392 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-13 Conversion : show line 2 in the form Class A-1 Preferred −4,124 0 D
Loading xslF345X03/doc4.xml…